Atom Investors LP Pliant Therapeutics, Inc. Transaction History

Atom Investors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$14.14 - $19.59 $117,319 - $162,538	-8,297 Reduced 12.5%	58,064 $865,000
Q4 2023 Feb 14, 2024	BUY	$12.85 - $19.15 $246,848 - $367,871	19,210 Added 40.74%	66,361 $1.2 Million
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $482,379 - $666,662	33,085 Added 235.21%	47,151 $817,000
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $159,564 - $269,111	-8,806 Reduced 38.5%	14,066 $254,000
Q1 2023 May 15, 2023	SELL	$18.73 - $36.26 $309,925 - $599,994	-16,547 Reduced 41.98%	22,872 $608,000
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $284,274 - $425,240	16,722 Added 73.67%	39,419 $761,000
Q3 2022 Nov 08, 2022	BUY	$7.67 - $24.23 $174,085 - $549,948	22,697 New	22,697 $474,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.